TRIM55 and colorectal carcinoma: Finally, the molecular mechanism of TRIM55 was investigated by immunoprecipitation and ubiquitination analyses.<h4>Results</h4>Here, we demonstrated that TRIM55 was markedly downregulated in CRC cell lines and tumors from CRC patients.